{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:44:48Z","timestamp":1778917488686,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuromuscular Diseases"],"published-print":{"date-parts":[[2023,1,3]]},"abstract":"<jats:p>A pilot newborn screening (NBS) program for Duchenne muscular dystrophy (DMD) study proposes to assess the feasibility of the screening procedure, temporal course of the various steps of screening, and the public acceptability of the program. This is particularly vital to ascertain as DMD is considered a \u2018non-treatable\u2019 disease and thus does not fit the traditional criteria for newborn screening. However, modern perspectives of NBS for DMD are changing and point to possible net benefits for children and their families undertaking NBS for DMD. The aim of this workshop was to establish pathways for the successful implementation and evaluation of a pilot NBS for DMD program in Australia. Consensus was reached as to the rationale for, potential benefits, risks, barriers and facilitators of screening, alongside the establishment of screening protocols and clinical referral pathways.<\/jats:p>","DOI":"10.3233\/jnd-221535","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T11:32:29Z","timestamp":1668166349000},"page":"15-28","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy"],"prefix":"10.1177","volume":"10","author":[{"given":"Michelle A.","family":"Farrar","sequence":"first","affiliation":[{"name":"Department of Paediatric Neurology, Sydney Children\u2019s Hospital Network, Sydney, NSW, Australia"},{"name":"Discipline of Paediatrics, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didu","family":"Kariyawasam","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Sydney Children\u2019s Hospital Network, Sydney, NSW, Australia"},{"name":"Discipline of Paediatrics, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Grattan","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Sydney Children\u2019s Hospital Network, Sydney, NSW, Australia"},{"name":"Discipline of Paediatrics, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klair","family":"Bayley","sequence":"additional","affiliation":[{"name":"Harry Perkins Institute of Medical Research, The University of Western Australia, Nedlands, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Holland","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Sydney Children\u2019s Hospital Network, Sydney, NSW, Australia"},{"name":"Discipline of Paediatrics, School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh B.","family":"Waddel","sequence":"additional","affiliation":[{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia"},{"name":"Kids Neuroscience Centre, The Children\u2019s Hospital at Westmead, Westmead, NSW, Australia"},{"name":"Discipline of Paediatrics, University of Sydney, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Jones","sequence":"additional","affiliation":[{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Lorentzos","sequence":"additional","affiliation":[{"name":"The T.Y. Nelson Department of Neurology and Neurosurgery, The Children\u2019s Hospital at Westmead, Sydney, NSW, Australia"},{"name":"Kids Neuroscience Centre, The Children\u2019s Hospital at Westmead, Westmead, NSW, Australia"},{"name":"Discipline of Paediatrics, University of Sydney, Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Ravine","sequence":"additional","affiliation":[{"name":"NSW Newborn Screening Programme, Children\u2019s Hospital Westmead, Westmead, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Wotton","sequence":"additional","affiliation":[{"name":"NSW Newborn Screening Programme, Children\u2019s Hospital Westmead, Westmead, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Wiley","sequence":"additional","affiliation":[{"name":"NSW Newborn Screening Programme, Children\u2019s Hospital Westmead, Westmead, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the DMD NBS Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","unstructured":"TowbinJA HejtmancikJF BrinkP GelbB ZhuXM ChamberlainJS et al X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993;87.","DOI":"10.1161\/01.CIR.87.6.1854"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c140048"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00007.2015"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0553"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23528"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5030027"},{"key":"e_1_3_3_8_2","unstructured":"PerkinElmerI PerkinElmer Launches First FDA-Approved Assay Kit to Screen for Duchenne Muscular Dystrophy in Newborns 2021 December 15 2021. Available from: https:\/\/ir.perkinelmer.com\/news-releases\/news-release-details\/perkinelmer-launches-first-fda-approved-assay-kit-screen."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-017-0036-3"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04307-7"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijns3020008"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20031"},{"key":"e_1_3_3_13_2","unstructured":"Institute\u2019 TM Living with Duchenne & Becker in Australia: Supporting Families waiting for a Cure. 2020."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.301"},{"key":"e_1_3_3_15_2","unstructured":"Health ADo Newborn Bloodspot Screening National Policy Framework. 2018."},{"key":"e_1_3_3_16_2","unstructured":"WilsonJMG JungnerG World Health O Principles and practice of screening for disease J. M. G. Wilson G. Jungner. Geneva: World Health Organization; 1968."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-anzan.22"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306971"},{"issue":"3","key":"e_1_3_3_19_2","first-page":"129","article-title":"Molecular diagnosis of duchenne muscular dystrophy: past, present and future in relation to implementing therapies","volume":"32","author":"Laing NG","year":"2011","unstructured":"LaingNG, DavisMR, BayleyK, FletcherS, WiltonSDMolecular diagnosis of duchenne muscular dystrophy: past, present and future in relation to implementing therapies. Clin Biochem Rev. 2011;32(3):129\u201334.","journal-title":"Clin Biochem Rev"},{"issue":"6136","key":"e_1_3_3_20_2","first-page":"1047","article-title":"Point-counterpoint","volume":"340","author":"McGuire AL","year":"2013","unstructured":"McGuireAL, JoffeS, KoenigBA, BieseckerBB, McCulloughLB, Blumenthal-BarbyJS, et alPoint-counterpoint. Ethics and genomic incidental findings. Science. 2013;340(6136):1047\u20138.","journal-title":"Ethics and genomic incidental findings. Science"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12298"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.13"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20031"},{"issue":"8","key":"e_1_3_3_24_2","first-page":"749","article-title":"Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study","volume":"115","author":"Hutton EM","year":"1976","unstructured":"HuttonEM, ThompsonMWCarrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Can Med Assoc J. 1976;115(8):749\u201352.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2018.01003"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes11070765"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8396429"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/gte.1998.2.55"},{"issue":"9","key":"e_1_3_3_29_2","first-page":"721","article-title":"GP 10 10 Newborn screening for Duchenne muscular dystrophy","volume":"16","author":"Eyskens F","year":"2006","unstructured":"EyskensF, PhilipsEGP 10 10 Newborn screening for Duchenne muscular dystrophy. The experience in the province of AntwerNeuromuscular Disorders. 2006;16(9):721.","journal-title":"The experience in the province of AntwerNeuromuscular Disorders"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320390115"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.301"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.301"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/fn.86.2.F91"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24880"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24100"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000669"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24965"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30026-7"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30024-3"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30025-5"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.09.007"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2020-0095"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2019-0171"},{"key":"e_1_3_3_44_2","unstructured":"MarkateT OskouiM FarrarM DuongT GoemensN ServaisL Emerging therapies for Duchenne Muscular Dystrophy. TBC. (Under Review). 2022."},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2021.09.010"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82725-z"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24191"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-7102"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","unstructured":"ChienY-H LeeN-C WengW-C ChenL-C HuangY-H WuC-S et al Duchenne muscular dystrophy newborn screening: the first 50 000 newborns screened in Taiwan. Neurological Sciences. 2022.","DOI":"10.1007\/s10072-022-06128-2"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.08.001"},{"key":"e_1_3_3_51_2","unstructured":"Health Do National Strategic Action Plan for Rare Disease. 2020."}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-221535","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JND-221535","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-221535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:52:16Z","timestamp":1777506736000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JND-221535"}},"subtitle":["<i>First Workshop Report: Establishing Australian health system readiness for the implementation and evaluation of a pilot program in New South Wales and the Australian Capital Territory<\/i>"],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,3]]}},"alternative-id":["10.3233\/JND-221535"],"URL":"https:\/\/doi.org\/10.3233\/jnd-221535","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}